Search research articles
Contact Us
Filters
Showing results (311-320 of 326) with videos related to
Page
of 33
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 17, 2021
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine
Anthony T Podany, Michelle Pham, Erin Sizemore, et al.
JAMA Network Open
|
March 16, 2022
Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial
Michael A Puskarich, Nicholas E Ingraham, Lisa H Merck, et al.
Nature Communications
|
January 19, 2023
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Nature Communications
|
August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Elife
|
February 21, 2022
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
Christopher J Brereton, Liudi Yao, Elizabeth R Davies, et al.
Page
of 33
Search research articles
Search
Showing results (311-320 of 326) with videos related to
Sort By:
Page
of 33
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 17, 2021
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine
Anthony T Podany, Michelle Pham, Erin Sizemore, et al.
JAMA Network Open
|
March 16, 2022
Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial
Michael A Puskarich, Nicholas E Ingraham, Lisa H Merck, et al.
Nature Communications
|
January 19, 2023
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Nature Communications
|
August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
JAMA Network Open
|
April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical Trials
Rachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Annals of Internal Medicine
|
April 17, 2023
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
Teresa H Evering, Kara W Chew, Mark J Giganti, et al.
Open Forum Infectious Diseases
|
September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy
Rinki Deo, Manish C Choudhary, Owen T Glover, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 21, 2021
Emergence of SARS-CoV-2 Resistance with Monoclonal Antibody Therapy
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Nature Microbiology
|
October 27, 2022
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
Manish C Choudhary, Kara W Chew, Rinki Deo, et al.
Elife
|
February 21, 2022
Pseudohypoxic HIF pathway activation dysregulates collagen structure-function in human lung fibrosis
Christopher J Brereton, Liudi Yao, Elizabeth R Davies, et al.
Page
of 33